{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "NSAID",
      "SARS-CoV-2",
      "anaesthetic drugs",
      "opioid",
      "premedication"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33934887",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "11",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bja.2021.03.026",
      "S0007-0912(21)00214-2"
    ],
    "Journal": {
      "ISSN": "1471-6771",
      "JournalIssue": {
        "Volume": "127",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "British journal of anaesthesia",
      "ISOAbbreviation": "Br J Anaesth"
    },
    "ArticleTitle": "Anaesthesia-related drugs and SARS-CoV-2 infection.",
    "Pagination": {
      "StartPage": "e32",
      "EndPage": "e34",
      "MedlinePgn": "e32-e34"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Electronic address: hirotak@hirosaki-u.ac.jp."
          }
        ],
        "LastName": "Hirota",
        "ForeName": "Kazuyoshi",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, UK."
          }
        ],
        "LastName": "Lambert",
        "ForeName": "David G",
        "Initials": "DG"
      }
    ],
    "PublicationTypeList": [
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Anaesth",
    "NlmUniqueID": "0372541",
    "ISSNLinking": "0007-0912"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anesthetics"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Br J Anaesth. 2021 Dec;127(6):e215-e218",
      "PMID": "34635287"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "metabolism"
      ],
      "DescriptorName": "Anesthetics"
    },
    {
      "QualifierName": [
        "metabolism",
        "surgery"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "Declarations of interest DGL is Chairman of BJA. KH has no conflicts of interest to declare."
}